Asia-Pacific Americas Africa Europe Middle East

JABER EBNE HAYYAN PHARMACEUTIC

Company Profile:



Business Nature: Manufacturer

Company Profile:

Jaber Ebne Hayyan Pharmaceutical Co. is one of the leading pharmaceutical companies in Iran, established in 1960. The company specializes in the research, development, and production of a wide range of pharmaceutical products. Its manufacturing capabilities cover various dosage forms, including injectables, tablets, capsules, and syrups. The company operates modern production facilities that adhere to Good Manufacturing Practice (GMP) standards, ensuring high-quality standards for both domestic and international markets. As a prominent player in the Iranian healthcare sector, Jaber Ebne Hayyan focuses on producing essential medicines, including antibiotics, hormonal drugs, and specialized therapeutic agents, contributing significantly to the national pharmaceutical industry.

Enterprise Products

JABER EBNE HAYYAN PHARMACEUTICAL COMPANY PRODUCT LIST

Injectables:

- Ampicillin Sodium for Injection

- Cloxacillin Sodium for Injection

- Ceftriaxone Sodium for Injection

- Cefazolin Sodium for Injection

- Cefotaxime Sodium for Injection

- Ceftazidime for Injection

- Hydrocortisone Sodium Succinate for Injection

- Methylprednisolone Sodium Succinate for Injection

Oral Dosage Forms:

- Amoxicillin Capsules

- Ampicillin Capsules

- Cloxacillin Capsules

- Cephalexin Capsules

- Erythromycin Tablets

- Metronidazole Tablets

- Dexamethasone Tablets

- Prednisolone Tablets

- Folic Acid Tablets

- Chlorpheniramine Maleate Tablets

Topical and Other Products:

- Various Antibiotic Ointments

- Corticosteroid Creams

- Specialized Pharmaceutical Raw Materials and API intermediates

Business Registration Information:

Manager:

Dr. Mohammad Reza Shanehsaz

Phone:

No Data

E-mail:

info@jaberpharma.com

Official Website:
Address:

Km 20, Karaj Special Road, Tehran, Iran

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.